Unknown

Dataset Information

0

Costs of integrating hypertension care into HIV care in rural East African clinics.


ABSTRACT:

Objective

Sub-Saharan Africa faces twin epidemics of HIV and noncommunicable diseases including hypertension. Integrating hypertension care into chronic HIV care is a global priority, but cost estimates are lacking. In the SEARCH Study, we performed population-level HIV/hypertension testing, and offered integrated streamlined chronic care. Here, we estimate costs for integrated hypertension/HIV care for HIV-positive individuals, and costs for hypertension care for HIV-negative individuals in the same clinics.

Design

Microcosting analysis of healthcare expenditures within Ugandan HIV clinics.

Methods

SEARCH (NCT: 01864603) conducted community health campaigns for diagnosis and linkage to care for both HIV and hypertension. HIV-positive patients received hypertension/HIV care jointly including blood pressure monitoring and medications; HIV-negative patients received hypertension care at the same clinics. Within 10 Ugandan study communities during 2015-2016, we estimated incremental annual per-patient hypertension care costs using micro-costing techniques, time-and-motion personnel studies, and administrative/clinical records review.

Results

Overall, 70 HIV-positive and 2355 HIV-negative participants received hypertension care. For HIV-positive participants, average incremental cost of hypertension care was $6.29 per person per year, a 2.1% marginal increase over prior estimates for HIV care alone. For HIV-negative participants, hypertension care cost $11.39 per person per year, a 3.8% marginal increase over HIV care costs. Key costs for HIV-positive patients included hypertension medications ($6.19 per patient per year; 98% of total) and laboratory testing ($0.10 per patient per year; 2%). Key costs for HIV-negative patients included medications ($5.09 per patient per year; 45%) and clinic staff salaries ($3.66 per patient per year; 32%).

Conclusion

For only 2-4% estimated additional costs, hypertension care was added to HIV care, and also expanded to all HIV-negative patients in prototypic Ugandan clinics, demonstrating substantial synergy. Our results should encourage accelerated scale-up of hypertension care into existing clinics.

SUBMITTER: Shade SB 

PROVIDER: S-EPMC8030915 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objective</h4>Sub-Saharan Africa faces twin epidemics of HIV and noncommunicable diseases including hypertension. Integrating hypertension care into chronic HIV care is a global priority, but cost estimates are lacking. In the SEARCH Study, we performed population-level HIV/hypertension testing, and offered integrated streamlined chronic care. Here, we estimate costs for integrated hypertension/HIV care for HIV-positive individuals, and costs for hypertension care for HIV-negative individual  ...[more]

Similar Datasets

| S-EPMC6143350 | biostudies-literature
| S-EPMC7305611 | biostudies-literature
| S-EPMC6553742 | biostudies-literature
| S-EPMC9371294 | biostudies-literature
| S-EPMC6436499 | biostudies-literature
| S-EPMC10927304 | biostudies-literature
| S-EPMC11785290 | biostudies-literature
| S-EPMC11015176 | biostudies-literature
| S-EPMC8011055 | biostudies-literature
| PRJNA626002 | ENA